6 completed, 2 unknown, 1 recruiting. 2 Not applicable, 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Coloring Agents: new trials by email Literature Review of Coloring Agents trials Research Report on Coloring Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting to Reduce Post-operative Pain and Surgical Morbidity During Endometriosis Surgery Ureteric stenting, Indocyanine green (ICG) dye - Endometriosis, Deep Endometriosis | Recruiting | University Hospitals of North Midlands NHS Trust | 70 | 2025-07-29 | 2025-09-03 | |
| Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General Anesthesia Methylene Blue, Standard Surgical Care Without Dye - Breast Cancer, Breast Surgery | Completed | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 220 | 2025-07-01 | 2026-04-30 | |
| Hepatic Safety of Statin Use in Neurology Inpatients stain - Statin Adverse Reaction | Unknown | Shanghai Yueyang Integrated Medicine Hospital | 2000 | 2024-08-10 | 2024-09-19 | |
| Near-infrared Fluorescence Lymphatic Imaging Assessment of Lymphatic Response to Pneumatic Back/Neck Lymphatic Drainage Delivered by a Pneumatic Manual Lymphatic Drainage Device Indocyanine green (ICG) dye, NIRF-LI imaging, Neuroglide pad - Neck Pain, Back Pain | Phase 1 | Completed | The University of Texas Health Science Center, Houston | 4 | 2023-08-29 | 2023-12-14 |
| Per-operative Exploration of the Peri-pancreatic Lymphatic Pathways During Pancreatic Surgical Resection Dye - Pancreatic Resection | Not applicable | Unknown | CHU de Reims | 20 | 2018-10-22 | 2019-12-16 |
| Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery Cytoflavin® solution, Cytoflavin® enteric-coated tablet, Placebo solution - Cognitive Dysfunction | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 200 | 2017-06-02 | 2023-01-31 |
| Laparoscopic Tubal Patency Assessment methylen blue &normal saline, methylene blue, metheylne blue with normal saline - Methylene Blue, Laparoscopy | Not applicable | Completed | Pourmatroud, Elham, M.D. | 30 | 2012-09-01 | 2017-04-11 |
| Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery temozolomide, flow cytometry, staining method - Recurrent Melanoma, Stage IV Melanoma | Phase 2 | Completed | Mayo Clinic | 25 | 2011-01-01 | 2020-10-22 |
| Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation therapeutic allogeneic lymphocytes, aldesleukin, peripheral blood stem cell transplantation - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 / Phase 2 | Completed | Fred Hutchinson Cancer Center | 37 | 2002-09-01 | 2017-03-29 |
Anemia, Refractory, with Excess of Blasts (1) · Back Pain (1) · Breast Neoplasms (1) · Cognitive Dysfunction (1) · Congenital Abnormalities (1) · Endometriosis (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Melanoma (1) · Neck Pain (1) · Polycythemia Vera (1) · Postoperative Cognitive Complications (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Thrombocythemia, Essential (1)
CHU de Reims (1) · Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital (1) · Fred Hutchinson Cancer Center (1) · Mayo Clinic (1) · POLYSAN Scientific & Technological Pharmaceutical Company (1) · Pourmatroud, Elham, M.D. (1) · Shanghai Yueyang Integrated Medicine Hospital (1) · The University of Texas Health Science Center, Houston (1) · University Hospitals of North Midlands NHS Trust (1)
United States (3) · China (1) · France (1) · Iran (1) · Russia (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Melissa B Aldrich, PhD, MBA (1) · Merav Bar (1) · Roxana Dronca, M.D. (1) · Tatiana V Kharitonova, MD, PhD (1)
P01CA018029 (1)